Oshika, Tetsuro
Nakano, Shinichiro
Fujita, Yoshifumi
Nomura, Yuya
Inoue, Yasushi
Takehara, Hiroyasu
Miyata, Kazunori
Honbou, Masato
Sugita, Toru
Kaneko, Tsutomu
Article History
Received: 16 October 2021
Accepted: 10 May 2022
First Online: 19 May 2022
Competing interests
: Dr. Tetsuro Oshika received compensation as a consultant from Alcon, Johnson & Johnson Vision, Santen Pharmaceutical, and Mitsubishi Tanabe. He receives research support from Santen Pharmaceutical, Tomey, Alcon, Senju Pharmaceutical, Johnson & Johnson Vision, HOYA, KOWA Pharmaceutical, Otsuka Pharmaceutical, Novartis, Pfizer, and Topcon. Other authors do not have any conflict of interest.